Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00404378 · ClinicalTrials.gov registry record · Phase 1
Study Of Healthy Subjects To Assess The Effect Of Ketoconazole And The Way The Body Will React To Casopitant [GW679769]
A Phase 1 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT00404378 is a Phase 1 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 15 participants.
The verdict
NCT00404378, a Phase 1 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
This is a two period study of healthy adult subjects to characterize the effect of the dosing of ketoconazole on the the way the body reacts to a dose of GW679769, and to assess the safety profile of oral casopitant with and without ketoconazole. This study will consist of a screening period, two treatment periods and a post-treatment follow-up visit.
Interventions
- DRUG ketoconazole
- DRUG casopitant 100 mg
- DRUG Casopitant 50 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2006-10-20 |
| Est. Completion | 2007-01-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00404378
The ClinicalTrials.gov registry entry for NCT00404378 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which ketoconazole is the first listed.
NCT00404378 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00404378 about?
NCT00404378 is a clinical study titled "Study Of Healthy Subjects To Assess The Effect Of Ketoconazole And The Way The Body Will React To Casopitant [GW679769]". This is a two period study of healthy adult subjects to characterize the effect of the dosing of ketoconazole on the the way the body reacts to a dose of GW679769, and to assess the safety profile of oral casopitant with and without ketoconazole. This study will consist of a screening period, two tr...
What is the current status of trial NCT00404378?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2006-10-20. Estimated completion is 2007-01-05.
What interventions are being tested in trial NCT00404378?
The interventions under investigation include: ketoconazole (DRUG), casopitant 100 mg (DRUG), Casopitant 50 mg (DRUG).
Who is sponsoring clinical trial NCT00404378?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.